Condition: Cancer Metastatic · Sponsor: Canadian Cancer Trials Group
This study is being done to answer the following question: Is Stereotactic Body Radiation Therapy or SBRT (a form of radiation therapy which can deliver high doses of radiation to the specific painful area of the body most affected by cancer, while keeping the radiation beams away from the healthy parts of the body that surround the cancer) better for pain relief than the standard treatment of conventional radiation therapy or CRT (a form of radiation therapy which delivers radiation to the painful area but can also negatively affect other parts of the body in the same area)
This description comes directly from the study's public registry record.
Wendy Parulekar · 613-533-6430 · wparulekar@ctg.queensu.ca
Always discuss trial participation with your own doctor first.
| BCCA - Vancouver | Vancouver, British Columbia, Canada | Recruiting |
| Juravinski Cancer Centre at Hamilton Health Sciences | Hamilton, Ontario, Canada | Recruiting |
| Kingston Health Sciences Centre | Kingston, Ontario, Canada | Recruiting |
| London Health Sciences Centre Research Inc. | London, Ontario, Canada | Recruiting |
| Stronach Regional Health Centre at Southlake | Newmarket, Ontario, Canada | Recruiting |
| Odette Cancer Centre | Toronto, Ontario, Canada | Recruiting |
| University Health Network | Toronto, Ontario, Canada | Recruiting |
| CHUM-Centre Hospitalier de l'Universite de Montreal | Montreal, Quebec, Canada | Recruiting |
| Hotel-Dieu de Quebec | Québec, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06391242